{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anxiety", "Depression", "Herbal products", "Self-medication"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33610705", "DateCompleted": {"Year": "2021", "Month": "03", "Day": "18"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "21"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "02", "Day": "18"}], "Language": ["eng"], "ELocationID": ["10.1016/j.jep.2021.113952", "S0378-8741(21)00178-1"], "Journal": {"ISSN": "1872-7573", "JournalIssue": {"Volume": "272", "PubDate": {"Year": "2021", "Month": "May", "Day": "23"}}, "Title": "Journal of ethnopharmacology", "ISOAbbreviation": "J Ethnopharmacol"}, "ArticleTitle": "Self-treatment and adverse reactions with herbal products for treating symptoms associated with anxiety and depression in adults from the central-western region of Mexico during the Covid-19 pandemic.", "Pagination": {"StartPage": "113952", "MedlinePgn": "113952"}, "Abstract": {"AbstractText": ["There are plant species used in the Mexican traditional medicine for the empirical treatment of anxiety and depression.", "This work assessed the prevalence of self-medication with medicinal plants and the prevalence of the concomitant use of prescribed psychiatric drugs and medicinal plants for treating symptoms associated with anxiety and depression during the Covid-19 lockdown in Mexico.", "The suspected adverse reactions associated with drug-herb interactions were assessed. The factors associated with self-medication, the concomitant use of herb-drug combinations, and the presence of adverse reactions due their combined use is also reported. The study was descriptive and cross-sectional using an online questionnaire conducted among population with symptoms associated with anxiety and depression (n\u00a0=\u00a02100) from seven states of central-western Mexico.", "The prevalence of the use of herbs (61.9%) and the concomitant use of drug-herb combinations (25.3%) were associated with being diagnosed with mental illness [OR:2.195 (1.655-2.912)] and the use of psychiatric medications [OR:307.994 (178.609-531.107)], respectively. The presence of adverse reactions (n\u00a0=\u00a0104) by the concomitant use of drug-herb combinations was associated with being unemployed [p\u00a0=\u00a00.004, OR: 3.017 (1.404-6.486)].", "Health professionals should be aware if their patients concomitantly use medicinal plants and psychiatric drugs. Public health campaigns should promote the possible adverse reactions that might produce the concomitant use of drug-herb combinations for mental illnesses."], "CopyrightInformation": "Copyright \u00a9 2021 Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Farmacia, Divisi\u00f3n de Ciencias Naturales y Exactas, Universidad de Guanajuato, Guanajuato, Mexico. Electronic address: angeljosabad@ugto.mx."}], "LastName": "Alonso-Castro", "ForeName": "Angel Josabad", "Initials": "AJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Farmacia, Divisi\u00f3n de Ciencias Naturales y Exactas, Universidad de Guanajuato, Guanajuato, Mexico."}], "LastName": "Ruiz-Padilla", "ForeName": "Alan Joel", "Initials": "AJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Doctorado Interinstitucional en Arte y Cultura, Universidad Aut\u00f3noma de Aguascalientes, Aguascalientes, Aguascalientes, Mexico."}], "LastName": "Ortiz-Cortes", "ForeName": "Miriam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto de Investigaci\u00f3n de Zonas Des\u00e9rticas, Universidad Aut\u00f3noma de San Luis Potos\u00ed, San Luis Potos\u00ed, Mexico, Mexico."}], "LastName": "Carranza", "ForeName": "Eleazar", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Farmacia, Divisi\u00f3n de Ciencias Naturales y Exactas, Universidad de Guanajuato, Guanajuato, Mexico."}], "LastName": "Ram\u00edrez-Morales", "ForeName": "Marco Antonio", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Farmacobiolog\u00eda, Centro Universitario de Ciencias Exactas e Ingenierias, Universidad de Guadalajara, Guadadalajara, Jalisco, Mexico."}], "LastName": "Escutia-Guti\u00e9rrez", "ForeName": "Raymundo", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Ciencias M\u00e9dicas, Divisi\u00f3n de Ciencias de La Salud, Universidad de Guanajuato, Le\u00f3n, Guanajuato, Mexico."}], "LastName": "Ruiz-Noa", "ForeName": "Yeniley", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Farmacia, Divisi\u00f3n de Ciencias Naturales y Exactas, Universidad de Guanajuato, Guanajuato, Mexico."}], "LastName": "Zapata-Morales", "ForeName": "Juan Ramon", "Initials": "JR"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "J Ethnopharmacol", "NlmUniqueID": "7903310", "ISSNLinking": "0378-8741"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Preparations"}, {"RegistryNumber": "0", "NameOfSubstance": "Psychotropic Drugs"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adolescent"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Anxiety"}, {"QualifierName": ["psychology"], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Communicable Disease Control"}, {"QualifierName": [], "DescriptorName": "Cross-Sectional Studies"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Depression"}, {"QualifierName": [], "DescriptorName": "Drug Interactions"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug therapy", "psychology"], "DescriptorName": "Mental Disorders"}, {"QualifierName": ["epidemiology"], "DescriptorName": "Mexico"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Pandemics"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Plant Preparations"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Prevalence"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Psychotropic Drugs"}, {"QualifierName": [], "DescriptorName": "Self Care"}, {"QualifierName": [], "DescriptorName": "Surveys and Questionnaires"}, {"QualifierName": ["psychology"], "DescriptorName": "Unemployment"}, {"QualifierName": [], "DescriptorName": "Young Adult"}], "CoiStatement": "Conflict of interest. The authors have no conflicts of interest to declare."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Alonso-Castro A.J., Dom\u00ednguez F., Maldonado-Miranda J.J., Castillo-P\u00e9rez L.J., Carranza-\u00c1lvarez C., Solano E., Isiordia-Espinoza M.A., Del Carmen Ju\u00e1rez-V\u00e1zquez M., Zapata-Morales J.R., Argueta-Fuertes M.A., Ruiz-Padilla A.J., Solorio-Alvarado C.R., Rangel-Vel\u00e1zquez J.E., Ortiz-Andrade R., Gonz\u00e1lez-S\u00e1nchez I., Cruz-Jim\u00e9nez G., Orozco-Castellanos L.M. Use of medicinal plants by health professionals in Mexico. J. Ethnopharmacol. 2017;198:81\u201386.", "ArticleIdList": ["28025163"]}, {"Citation": "Amsterdam J.D., Shults J., Soeller I., Mao J.J., Rockwell K., Newberg A.B. Chamomile (Matricaria recutita) may provide antidepressant activity in anxious, depressed humans: an exploratory study. Alternative Ther. Health Med. 2012;18(5):44\u201349.", "ArticleIdList": ["PMC3600408", "22894890"]}, {"Citation": "Asociaci\u00f3n mexicana de Agencias de Inteligencia de Mercado y opini\u00f3n [Mexican association of Market intelligence] 2018. http://nse.amai.org/wp-content/uploads/2018/04/Cuestionario-NSE-2018.pdf Available at:"}, {"Citation": "Bahorik A.L., Sterling S.A., Campbell C.I., Weisner C., Ramo D., Satre D.D. Medical and non-medical marijuana use in depression: longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization. J. Affect. Disord. 2018;241:8\u201314.", "ArticleIdList": ["PMC6455811", "30086434"]}, {"Citation": "Berenzon S., Saavedra N. Presencia de la herbolaria en el tratamiento de los problemas emocionales: entrevista a los curanderos urbanos. Salud Ment. 2002;25(1):55\u201366."}, {"Citation": "Berenzon-Gorn S., Alan\u00eds-Navarro S., Saavedra-Solano N. El uso de las terapias alternativas y complementarias en poblaci\u00f3n mexicana con trastornos depresivos y de ansiedad: resultados de una encuesta en la Ciudad de M\u00e9xico. Salud Ment. 2009;32(2):107\u2013115."}, {"Citation": "Bystritsky A., Hovav S., Sherbourne C., Stein M.B., Rose R.D., Campbell-Sills L., Golinelli D., Sullivan G., Craske M.G., Roy-Byrne P.P. Use of complementary and alternative medicine in a large sample of anxiety patients. Psychosomatics. 2012;53(3):266\u2013272.", "ArticleIdList": ["PMC4014348", "22304968"]}, {"Citation": "Cordell G.A., Colvard M.D. Natural products and traditional medicine: turning on a paradigm. J. Nat. Prod. 2012;75:514\u2013525.", "ArticleIdList": ["22233451"]}, {"Citation": "de Gobernaci\u00f3n Secretar\u00eda. 2020. Acuerdo por el que se declara como emergencia sanitaria por causa de fuerza mayor, a la epidemia de enfermedad generada por el virus SARS-CoV2 (COVID-19) M\u00e9xico. Published."}, {"Citation": "Diagnostic and Statistical Manual of Mental Disorders 4th Ed. (DSM-IV) American Psychiatric Association; Washington, DC: 1994. American Psychiatric Press, Inc. 1994."}, {"Citation": "Dom\u00ednguez F., Alonso-Castro A.J., Anaya M., Gonz\u00e1lez-Trujano M.E., Salgado-Ceballos H., Orozco-Su\u00e1rez S. In: Therapeutic Medicinal Plants. Rai M., Teixeira-Duarte M.C., editors. CRC Press; United Kingdom: 2015. Mexican traditional medicine: traditions of yesterday and phytomedicines of tomorrow Pp 1-37; p. 400."}, {"Citation": "DRUG-REAX System [internet Database] Thomson Reuters (Healthcare); Greenwood Village, CO: 2009."}, {"Citation": "Elkins G., Marcus J., Rajab M.H., Durgam S. Complementary and alternative therapy use by psychotherapy clients. Psychother. Theor. Res. Pract. Train. 2005;42(2):232\u2013235."}, {"Citation": "Fryers T., Melzer D., Jenkins R., Brugha T. The distribution of the common mental disorders: social inequalities in Europe. Clin. Pract. Epidemiol. Ment. Health: CP EMH. 2005;1:14.", "ArticleIdList": ["PMC1242241", "16143042"]}, {"Citation": "Galindo-V\u00e1zquez O., Ram\u00edrez-Orozco M., Costas-Mu\u00f1iz R., Mendoza-Contreras L.A., Calderillo-Ru\u00edz G., Meneses-Garc\u00eda A. Symptoms of anxiety, depression and self-care behaviors during the COVID-19 pandemic in the general population. Gac. Med. Mex. 2020;156:298\u2013305.", "ArticleIdList": ["PMC8327400", "32831341"]}, {"Citation": "Gao K., Kemp D.E., Fein E., Wang Z., Fang Y., Ganocy S.J., Calabrese J.R. Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychotics. J. Clin. Psychiatr. 2011;72(8):1063\u20131071.", "ArticleIdList": ["PMC3457049", "21034695"]}, {"Citation": "Geck M.S., Cristians S., Berger-Gonz\u00e1lez M., Casu L., Heinrich M., Leonti M. Traditional herbal medicine in Mesoamerica: toward its evidence base for improving universal health coverage. Front. Pharmacol. 2020;11:1160.", "ArticleIdList": ["PMC7411306", "32848768"]}, {"Citation": "Griebel G., Holmes A. 50 years of hurdles and hope in anxiolytic drug discovery. Nat. Rev. Drug Discov. 2013;12:667\u2013687.", "ArticleIdList": ["PMC4176700", "23989795"]}, {"Citation": "Guzm\u00e1n-Guti\u00e9rrez S.L., Reyes-Chilpa R., Bonilla-Jaime H. Medicinal plants for the treatment of \u201cnervios\u201d, anxiety, and depression in Mexican Traditional Medicine. Rev. Brasil. Farmacognosia. 2014;24(5):591\u2013608."}, {"Citation": "Horn J.R., Hansten P.D., Chan L.N. Proposal for new tool to evaluate drug interaction cases. Ann. Pharmacother. 2007;41(4):674\u2013680.", "ArticleIdList": ["17389673"]}, {"Citation": "Jobson M.D.  In: Second-generation Antipsychotic Medications: Pharmacology, Administration, and Side Effects. Post T.W., editor. UpToDate Inc; Waltham, MA: 2017. https://www.uptodate.com UpToDate."}, {"Citation": "Kress W.J., Wurdack K.J., Zimmer E.A., Weigt L.A., Janzen D.H. Use of DNA barcodes to identify flowering plants. Proc. Natl. Acad. Sci. U.S.A. 2005;102(23):8369\u20138374.", "ArticleIdList": ["PMC1142120", "15928076"]}, {"Citation": "LaFrance W.C., Jr., Lauterbach E.C., Coffey C.E., Salloway S.P., Kaufer D.I., Reeve A., Royall D.R., Aylward E., Rummans T.A., Lovell M.R. The use of herbal alternative medicines in neuropsychiatry. A report of the ANPA Committee on Research. J. Neuropsychiatr. Clin. Neurosci. 2000;12(2):177\u2013192.", "ArticleIdList": ["11001596"]}, {"Citation": "Li J., Yang Z., Qiu H., Wang Y., Jian L., Ji J., Li K. Anxiety and depression among general population in China at the peak of the COVID-19 epidemic. World Psychiatr. 2020;19(2):249\u2013250.", "ArticleIdList": ["PMC7214959", "32394560"]}, {"Citation": "L\u00f3pez-Rubalcava C., Estrada-Camarena E. Mexican medicinal plants with anxiolytic or antidepressant activity: focus on preclinical research. J. Ethnopharmacol. 2016;186:377\u2013391.", "ArticleIdList": ["27021688"]}, {"Citation": "Mao J.J., Xie S.X., Keefe J.R., Soeller I., Li Q.S., Amsterdam J.D. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: a randomized clinical trial. Phytomedicine. 2016;23(14):1735\u20131742.", "ArticleIdList": ["PMC5646235", "27912875"]}, {"Citation": "Medina-Mora M.E., Borges G., Lara C., Benjet C., Blanco J., Fleiz C., Villatoro J., Rojas E., Zambrano J., Casanova L., Aguilar S. Prevalencia de trastornos mentales y uso de servicios: resultados de la Encuesta Nacional de Epidemiolog\u00eda Psiqui\u00e1trica en M\u00e9xico. Salud Ment. 2003;26:1\u201316."}, {"Citation": "Medina-Mora M.E., Borges G., Benjet C., Lara C., Berglund P. Psychiatric Disorders in Mexico: lifetime prevalence in a nationally representative sample. Br. J. Psychiatry. 2007;190:521\u2013528.", "ArticleIdList": ["17541113"]}, {"Citation": "Moslemi F., Alijaniha F., Naseri M., Kazemnejad A., Charkhkar M., Heidari M.R. Citrus aurantium aroma for anxiety in patients with acute coronary syndrome: a double-blind placebo-controlled trial. J. Alternative Compl. Med. 2019;25(8):833\u2013839.", "ArticleIdList": ["31211612"]}, {"Citation": "Ngan A., Conduit R. A double-blind, placebo-controlled investigation of the effects of Passiflora incarnata (passionflower) herbal tea on subjective sleep quality. Phytother Res. 2011;25(8):1153\u20131159.", "ArticleIdList": ["21294203"]}, {"Citation": "Nikoli\u0107 G., Stojanovi\u0107 N.M., Randjelovi\u0107 P.J., Manojlovi\u0107 S., Radulovi\u0107 N.S. An epidemiological study on herbal product self-medication practice among psychotic outpatients from Serbia: a cross-sectional study. Saudi Pharmaceut. J. 2018;26(3):335\u2013341.", "ArticleIdList": ["PMC5856938", "29556124"]}, {"Citation": "Niv N., Shatkin J.P., Hamilton A.B., Un\u00fctzer J., Klap R., Young A.S. The use of herbal medications and dietary supplements by people with mental illness. Community Ment. Health J. 2010;46(6):563\u2013569.", "ArticleIdList": ["PMC2965367", "19688594"]}, {"Citation": "\u00d6zdin S., Bayrak \u00d6zdin \u015e. Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: the importance of gender. Int. J. Soc. Psychiatr. 2020;66(5):504\u2013511.", "ArticleIdList": ["PMC7405629", "32380879"]}, {"Citation": "Pang, X. H., Shi, L.C., Song, J.Y., Chen, X.C., & Chen, S.L. Use of the potential DNA barcode ITS2 to identify herbal materials. J. Nat. Med. 67, 571\u2013575.", "ArticleIdList": ["23179313"]}, {"Citation": "Parslow R.A., Jorm A.F. Use of prescription medications and complementary and alternative medicines to treat depressive and anxiety symptoms: results from a community sample. J. Affect. Disord. 2004;82(1):77\u201384.", "ArticleIdList": ["15465579"]}, {"Citation": "P\u00e9rez-Cano H.J., Moreno-Murgu\u00eda M.B., Morales-L\u00f3pez O., Crow-Buchanan O., English J.A., Lozano-Alc\u00e1zar J., Somilleda-Ventura S.A. Anxiety, depression, and stress in response to the coronavirus disease-19 pandemic. Cir. Cir. 2020;88(5):562\u2013568.", "ArticleIdList": ["33064695"]}, {"Citation": "Pimenta F.C., Alves M.F., Pimenta M.B., Melo S.A., de Almeida A.A., Leite J.R., Pordeus L.C., Diniz M., de Almeida R.N. Anxiolytic effect of Citrus aurantium L. on patients with chronic myeloid leukemia. Phytother Res. 2016;30(4):613\u2013617.", "ArticleIdList": ["26787366"]}, {"Citation": "Rafful C., Medina-Mora M.E., Borges G., Benjet C., Orozco R. Depression, gender and the treatment gap in Mexico. J. Affect. Disord. 2012;138:165\u2013169.", "ArticleIdList": ["22341482"]}, {"Citation": "Ravven S.E., Zimmerman M.B., Schultz S.K., Wallace R.B. 12-month herbal medicine use for mental health from the national Comorbidity Survey Replication (NCS-R) Ann. Clin. Psychiatr. 2011;23(2):83\u201394.", "ArticleIdList": ["21547268"]}, {"Citation": "Rodr\u00edguez-Carranza R. Los productos de Cannabis sativa: situaci\u00f3n actual y perspectivas en medicina. Salud Ment. 2012;35:247\u2013256."}, {"Citation": "Roy-Byrne P.P., Bystritsky A., Russo J., Craske M.G., Sherbourne C.D., Stein M.B. Use of herbal medicine in primary care patients with mood and anxiety disorders. Psychosomatics. 2005;46(2):117\u2013122.", "ArticleIdList": ["15774949"]}, {"Citation": "Stockley I.H., editor. Stockley's Drug Interactions. sixth ed. The Pharmaceutical Press; London, Chicago: 2002."}, {"Citation": "Stojanovi\u0107 N.M., Samard\u017ei\u0107 L., Randjelovi\u0107 P.J., Radulovi\u0107 N.S. Prevalence of self-medication practice with herbal products among non-psychotic psychiatric patients from southeastern Serbia: a cross-sectional study. Saudi Pharmaceut. J. 2017;25(6):884\u2013890.", "ArticleIdList": ["PMC5605899", "28951674"]}, {"Citation": "Sun W., Yan S., Li J., Xiong C., Shi Y., Wu L., Xiang L., Deng B., Ma W., Chen S. Study of commercially available Lobelia chinensis products using Bar-HRM technology. Front. Plant Sci. 2017;8:351.", "ArticleIdList": ["PMC5352710", "28360920"]}, {"Citation": "Teran-Perez G., Arana-Lechuga Y., Vel\u00e1zquez-Moctezuma Cambios en el sue\u00f1o y la salud mental por el aislamiento social durante la pandemia de Covid 19. Ciencia. 2020;71:66\u201371."}, {"Citation": "Valencia M. APM Ediciones y Convenciones en Psiquiatr\u00eda; 2018. Remisi\u00f3n Y Recuperaci\u00f3n Funcional [Remission and Functional Recovery]. En: Depresi\u00f3n, Trastornos Bipolar Y Esquizofrenia [depression, Bipolar Disorders and Schizophrenia] 978-607-8512-88-1."}, {"Citation": "Vasiladis H.M., Tempier R. Reporting on the prevalence of drug and alternative health product use for mental health reasons: results from a national population survey. Journal of Population Therapeutics and Clinical Pharmacology. 2011;18(1):e33\u2013e43.", "ArticleIdList": ["21317442"]}, {"Citation": "Woelk H., Arnoldt K.H., Kieser M., Hoerr R. Ginkgo biloba special extract EGb 761 in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trial. J. Psychiatr. Res. 2007;41(6):472\u2013480.", "ArticleIdList": ["16808927"]}, {"Citation": "World Health Organization (WHO) 2020. Novel Coronavirus(2019-nCoV) Situation Report-12."}, {"Citation": "Wu P., Fuller C., Liu X., Lee H.C., Fan B., Hoven C.W., Mandell D., Wade C., Kronenberg F. Use of complementary and alternative medicine among women with depression: results of a national survey. Psychiatr. Serv. 2007;58(3):349\u2013356.", "ArticleIdList": ["17325108"]}, {"Citation": "Zhang Y., Ma Z.F. Impact of the COVID-19 pandemic on mental health and quality of life among local residents in Liaoning Province, China: a cross-sectional study. Int. J. Environ. Res. Publ. Health. 2020;17(7):238.", "ArticleIdList": ["PMC7177660", "32244498"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "9", "Day": "8"}, {"Year": "2021", "Month": "2", "Day": "15"}, {"Year": "2021", "Month": "2", "Day": "16"}, {"Year": "2021", "Month": "2", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "21", "Hour": "20", "Minute": "29"}, {"Year": "2021", "Month": "2", "Day": "18"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33610705", "PMC9387533", "10.1016/j.jep.2021.113952", "S0378-8741(21)00178-1"]}}], "PubmedBookArticle": []}